SCHEMBL3473284

SCHEMBL3473284

CCCC[P+](CCCC)(CCCC)CCCC.O=S(=O)([O-])c1ccccc1

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.50
TDP1 Q9NUW8 1/20 0.46
MMP1 P03956 4/20 0.46
MMP7 P09237 4/20 0.46
MMP12 P39900 4/20 0.46
MMP13 P45452 4/20 0.46
ACE P12821 3/20 0.46
PSIP1 O75475 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.40
DNM1 Q05193 2/20 0.39
CNR2 P34972 2/20 0.38
PTGS2 P35354 1/20 0.38
ESR1 P03372 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10968743 0.94 NR1I2 (0.52) NR1I2TDP1MMP1MMP7MMP12
SCHEMBL4456395 0.93 NR1I2 (0.55) NR1I2TDP1MMP1MMP7MMP12
SCHEMBL4459089 0.93 NR1I2 (0.55) NR1I2TDP1MMP1MMP7MMP12
SCHEMBL10976891 0.92 NR1I2 (0.44) NR1I2TDP1MMP1MMP7MMP12
SCHEMBL21297026 0.88 NR1I2 (0.49) NR1I2TDP1MMP1MMP7MMP12
SCHEMBL305721 0.86 NR1I2 (0.50) NR1I2TDP1SMN1; SMN2ALDH1A1GAA
Phenolsulfonic Acid SCHEMBL23214379 0.84 NR1I2 (0.49) NR1I2ALDH1A1PTGS2ESR1CA2
SCHEMBL20565715 0.84 NR1I2 (0.49) NR1I2TDP1SMN1; SMN2ALDH1A1TSHR
SCHEMBL3671893 0.84 NR1I2 (0.49) NR1I2TDP1SMN1; SMN2ALDH1A1GAA
SCHEMBL3476257 0.83 CA2 (0.53) NR1I2SMN1; SMN2TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583256-B2 Comprising a resorcinol-isophthalic or terephthalic acid-co-bisphenol a polycarbonate block copolymer, a polyalkylene dicarboxylate, and at least one impact modifier; nonyellowing; articles such as car, truck, motorcycle panels GENERAL ELECTRIC COMPANY 2003-06-24 US claimed
US-20010016626-A1 Weatherable block copolyestercarbonate compositions SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2001-08-23 US claimed
CN-122095024-A Flame-retardant aromatic polycarbonate resin composition and molded article thereof 2026-05-26 CN disclosed
WO-2026100296-A1 FLAME-RETARDANT AROMATIC POLYCARBONATE RESIN MASTER BATCH AND METHOD FOR MANUFACTURING SAME 信越化学工業株式会社 2026-05-15 WO disclosed
EP-4696823-A1 POLYTRIMETHYLENE TEREPHTHALATE FIBER, METHOD FOR PRODUCING SAME, AIR-MIXED FILAMENT YARN CONTAINING SAID POLYTRIMETHYLENE TEREPHTHALATE FIBER, AND FABRIC COMPOSED THEREOF TEIJIN FRONTIER CO., LTD. (JP) 2026-02-18 EP disclosed
WO-2025088996-A1 FLAME-RETARDANT AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE OF SAME 信越化学工業株式会社 2025-05-01 WO disclosed
WO-2024214591-A1 POLYTRIMETHYLENE TEREPHTHALATE FIBER, METHOD FOR PRODUCING SAME, AIR-MIXED FILAMENT YARN CONTAINING SAID POLYTRIMETHYLENE TEREPHTHALATE FIBER, AND FABRIC COMPOSED THEREOF 帝人フロンティア株式会社 2024-10-17 WO disclosed
US-20240058452-A1 PHARMACEUTICAL COMPOSITION CONTAINING TEMPERATURE-RESPONSIVE IONIC LIQUID TORAY INDUSTRIES, INC. (JP) 2024-02-22 US disclosed
US-20230340259-A1 RESIN COMPOSITION, MOLDED ARTICLE, AND MACROMONOMER COPOLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 2023-10-26 US disclosed
EP-4253438-A1 RESIN COMPOSITION, MOLDED ARTICLE, AND MACROMONOMER COPOLYMER Mitsubishi Chemical Corporation (JP) 2023-10-04 EP disclosed
CN-114502142-B Pharmaceutical composition comprising temperature responsive ionic liquid 东丽株式会社 2023-05-09 CN disclosed
US-5696222-A MELT POLYCONDENSATION OF AN AROMATIC DIHYDROXY COMPOUND AND DIPHENYLCARBONATE, THEN ADDING A SPECIFIC CARBONATE OR CARBOCYCLIC ESTER TO FORM TERMINAL BLOCKED POLYCARBONATE TEIJIN LIMITED (JP) 1997-12-09 US disclosed
US-5668202-A ADDING ORGANOSULFONATE OR SULFATE STABILIZER AFTER MELT POLYCONDENSATION TEIJIN LIMITED (JP) 1997-09-16 US disclosed
EP-0764673-A2 Process for the production of polycarbonate TEIJIN LIMITED (JP) 1997-03-26 EP disclosed
US-5494952-A CATALYTIC MELT CONDENSATION OF AROMATIC DIHYDROXY COMPOUND AND A CARBONIC ACID DIESTER UNTIL DESIRED VISCOSITY IS REACHED, THEN MIXING WITH STABILIZER CONTAINING QUATERNARY AMMONIUM OR PHOSPHONIUM SALTS OF ORGANIC SULFONIC ACIDS TEIJIN LIMITED (JP) 1996-02-27 US disclosed
US-5486555-A Process for production of stabilized polycarbonate TEIJIN LIMITED (JP) 1996-01-23 US disclosed
EP-0678552-A1 Process for the preparation of modified polybutylene terephthalate resin POLYPLASTICS CO. LTD. (JP) 1995-10-25 EP disclosed
EP-0640646-A1 Process for production of stabilized polycarnonate TEIJIN LIMITED (JP) 1995-03-01 EP disclosed
US-4038258-A ANTISTATIC COMPOSITION CONTAINING AN ALIPHATIC POLYESTER OR POLYETHER ESTER AND A PHOSPHONIUM SALT E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-07-26 US disclosed
US-4005057-A Antistatic composition containing an N-alkyl polycarbonamide and a phosphonium salt E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240058452-A1 PHARMACEUTICAL COMPOSITION CONTAINING TEMPERATURE-RESPONSIVE IONIC LIQUID SULT1A1, CYP2C19, SULT2A1 NR1I2 910/4885TDP1 4126/4885MMP1 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.